Ependymoma, Recurrent Completed Phase 1 Trials for Aglatimagene besadenovec (DB15074)

Also known as: Ependymoma Recurrent / Recurrent Ependymoma

IndicationStatusPhase
DBCOND0106575 (Ependymoma, Recurrent)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00634231A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsTreatment